scorecardresearch
Follow Us:
Saturday, December 04, 2021

New research: An oral version of remdesivir

Manufacturer Gilead Sciences has partnered with researchers in Georgia State University to test a modified version of remdesivir that can be taken orally.

By: Express News Service | New Delhi |
November 9, 2021 10:28:00 am
An ampule of Gilead Sciences Covid-19 antiviral remdesivir. (Ulrich Perrey/Pool via Reuters/File Photo)

Remdesivir, which was once considered the most promising of the Covid-19 treatments that went through the Solidarity trials under the aegis of the World Health Organization (WHO), but which has since fallen out of favour, is delivered intravenously.

Now, manufacturer Gilead Sciences has partnered with researchers in Georgia State University to test a modified version of remdesivir that can be taken orally.

The research comes at a time when Merck and Ridgeback’s oral drug for Covid-19, molnupiravir, has received clearance from the UK, and when Pfizer has reported promising trial results of its own Covid-19 drug, Paxlovid. (Read more about it here)

On November 20, the WHO issued a conditional recommendation against the use of remdesivir in hospitalised patients, regardless of disease severity, as “there is currently no evidence that remdesivir improves survival and other outcomes in these patients”.

Researchers have now reported that the modified version of remdesivir was “highly effective” in suppressing SARS-CoV-2 replication and transmission in animals when given orally.

It could be “groundbreaking” in improving patient access to treatment early after infection, Georgia State University said in a press release.

The results of the study, done on ferrets, have been published in the journal Nature Communications.

📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines

For all the latest Explained News, download Indian Express App.

  • Newsguard
  • The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.
  • Newsguard
0 Comment(s) *
* The moderation of comments is automated and not cleared manually by indianexpress.com.
Advertisement
Advertisement
Advertisement
Advertisement